Atossa Share Price

Atossa Share Price

NASDAQ: ATOS | Healthcare
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Atossa Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
$0.53 - $7.50
Volume
N/A
Average Traded
N/A

Atossa Share Price Chart

Line chart of the Atossa price trend over the selected period. The price rose overall, ranging from 1.78 to 1.78, ending at 1.78.
$0.00$0.00
L
Show Current Price
H

Atossa Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.47
Revenue (TTM)
$0.00
Return On Equity (TTM)
-159.41%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
48.45%

Atossa Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$10.94-$9.59-$8.49-$5.64
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A12.34%11.47%33.57%

Atossa Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$26.96-$30.09-$25.50-$34.77
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-11.61%15.25%-36.35%

Atossa Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1.991.994.035.34
Current Assets45.6274.4692.22118.2
Total Assets47.6176.4496.25123.53
Non Current Liabilities0.00.00.00.0
Current Liabilities8.264.975.245.57
Total Liabilities8.264.975.245.57
Shareholders' Equity39.3571.4891.02117.96

Atossa Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-29.76-21.03-20.94-20.76
Investing-0.02-0.02-0.01-4.73
Financing0.03.67-1.480.0

Corporate Actions

Split
Ex-date: 02 Feb 2026

About Atossa

Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.

Atossa Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.27
$1.78
-18.35%
Oct 2026
$2.04
$2.18
+11.22%
Sep 2026
$2.44
$1.96
-25.19%
Aug 2026
$2.14
$2.62
+27.80%
Jul 2026
$1.94
$2.05
+5.94%
Jun 2026
$5.17
$1.94
-62.61%
May 2026
$5.87
$5.17
-4.70%
Apr 2026
$5.25
$5.43
+7.21%
Mar 2026
$4.30
$5.07
+16.17%
Feb 2026
$6.93
$4.36
+673.05%
Jan 2026
$0.60
$0.56
-3.42%
Dec 2025
$0.77
$0.58
-24.94%

Atossa Share Price FAQs